Ostoros G - Search Results

1

High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.

Bogos K, Renyi-Vamos F, Dobos J, Kenessey I, Tovari J, Timar J, Strausz J, Ostoros G, Klepetko W, Ankersmit HJ, Lang G, Hoda MA, Nierlich P, Dome B. Bogos K, et al. Among authors: ostoros g. Clin Cancer Res. 2009 Mar 1;15(5):1741-6. doi: 10.1158/1078-0432.CCR-08-1372. Epub 2009 Feb 24. Clin Cancer Res. 2009. PMID: 19240177

2

[Supportive therapy of lung cancer patients].

Bogos K, Ostoros G. Bogos K, et al. Among authors: ostoros g. Magy Onkol. 2000 Oct 1;44(3):227-233. Magy Onkol. 2000. PMID: 12050751 Free article. Hungarian.

3

[Effectiveness of Gemzar-Cisplatin therapy in stage IIIA-N2, IIIB and IV non-small cell lung cancer].

Ostoros G, Kovács G, Gergely-Farnos E, Magyar P, Szondy K, Strausz J, Ferenczi E. Ostoros G, et al. Magy Onkol. 2003;47(2):185-8. Epub 2003 Sep 16. Magy Onkol. 2003. PMID: 12975667 Free article. Clinical Trial. Hungarian.

4

Efficacy of gemcitabine--cisplatin treatment in stage IIIA ("bulky"N2), IIIB and IV non-small cell lung cancer.

Ostoros G, Szondy K, Gergely-Farnos E, Magyar P, Strausz J, Ferenczi E, Kovács G. Ostoros G, et al. Anticancer Res. 2005 Jan-Feb;25(1B):471-5. Anticancer Res. 2005. PMID: 15816614 Free article. Clinical Trial.

5

[New therapies for non-small cell lung cancer].

Ostoros G, Kovács G, Szondy K, Döme B. Ostoros G, et al. Orv Hetil. 2005 May 22;146(21):1135-41. Orv Hetil. 2005. PMID: 15991677 Review. Hungarian.

6

Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer.

Renyi-Vamos F, Tovari J, Fillinger J, Timar J, Paku S, Kenessey I, Ostoros G, Agocs L, Soltesz I, Dome B. Renyi-Vamos F, et al. Among authors: ostoros g. Clin Cancer Res. 2005 Oct 15;11(20):7344-53. doi: 10.1158/1078-0432.CCR-05-1077. Clin Cancer Res. 2005. PMID: 16243806

7

Inhibition of EGFR tyrosine-kinase in NSCLC treatment: the Hungarian experience with gefitinib in the context of an expanded access programme.

Ostoros G, Harisi R, Kovacs G, Horti J, Geczi L, Szondy K, Orosz M, Ferenczi E, Ruby E, Dome B. Ostoros G, et al. Anticancer Res. 2005 Nov-Dec;25(6C):4759-62. Anticancer Res. 2005. PMID: 16334173 Free article. Clinical Trial.

8

Fatal pulmonary fibrosis induced by paclitaxel: a case report and review of the literature.

Ostoros G, Pretz A, Fillinger J, Soltesz I, Dome B. Ostoros G, et al. Int J Gynecol Cancer. 2006 Jan-Feb;16 Suppl 1:391-3. doi: 10.1111/j.1525-1438.2006.00222.x. Int J Gynecol Cancer. 2006. PMID: 16515630

9

Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer.

Dome B, Timar J, Dobos J, Meszaros L, Raso E, Paku S, Kenessey I, Ostoros G, Magyar M, Ladanyi A, Bogos K, Tovari J. Dome B, et al. Among authors: ostoros g. Cancer Res. 2006 Jul 15;66(14):7341-7. doi: 10.1158/0008-5472.CAN-05-4654. Cancer Res. 2006. PMID: 16849585 Free article.

10

[Erlotinib in the treatment of non-small cell lung cancer].

Ostoros G, Döme B. Ostoros G, et al. Magy Onkol. 2006;50(3):237-41. Epub 2006 Nov 12. Magy Onkol. 2006. PMID: 17099784 Free article. Review. Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters